hVIVO plc
General ticker "OPORF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $179.1M (TTM average)
hVIVO plc does not follow the US Stock Market performance with the rate: -9.6%.
Estimated limits based on current volatility of 0.0%: low 0.24$, high 0.24$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-05-16, amount 0.00$ (Y0.00%)
Short-term OPORF quotes
Long-term OPORF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | £50.70MM | £56.04MM | £62.73MM |
| Operating Expenses | £44.67MM | £45.94MM | £49.87MM |
| Operating Income | £6.02MM | £10.10MM | £12.86MM |
| Non-Operating Income | £-6.39MM | £1.04MM | £0.43MM |
| Interest Expense | £0.13MM | £0.15MM | £0.95MM |
| R&D Expense | £0.08MM | £0.00MM | £0.00MM |
| Income(Loss) | £-0.36MM | £11.15MM | £13.29MM |
| Profit(Loss)* | £-0.78MM | £16.11MM | £10.65MM |
| Stockholders Equity | £20.22MM | £34.33MM | £44.67MM |
| Inventory | £0.50MM | £0.43MM | £0.80MM |
| Assets | £51.38MM | £83.23MM | £88.89MM |
| Operating Cash Flow | £15.98MM | £17.24MM | £10.34MM |
| Capital expenditure | £1.36MM | £5.18MM | £2.46MM |
| Investing Cash Flow | £-1.36MM | £-4.00MM | £-0.66MM |
| Financing Cash Flow | £-1.83MM | £-4.70MM | £-2.40MM |
| Earnings Per Share** | £-0.00 | £0.02 | £0.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.